Unresolved disorder model. using A
ATOM    431  N  AVAL    57      31.631  -7.970   4.212  0.50 25.76           N  
Unresolved disorder model. using A
ATOM    432  N  BVAL    57      31.647  -8.000   4.218  0.50 25.69           N  
Unresolved disorder model. using A
ATOM    433  CA AVAL    57      32.970  -8.117   4.774  0.50 27.54           C  
Unresolved disorder model. using A
ATOM    434  CA BVAL    57      32.949  -8.222   4.823  0.50 27.35           C  
Unresolved disorder model. using A
ATOM    435  C  AVAL    57      33.122  -7.516   6.172  0.50 28.83           C  
Unresolved disorder model. using A
ATOM    436  C  BVAL    57      32.948  -7.855   6.313  0.50 28.70           C  
Unresolved disorder model. using A
ATOM    437  O  AVAL    57      34.218  -7.547   6.726  0.50 29.08           O  
Unresolved disorder model. using A
ATOM    438  O  BVAL    57      33.746  -8.402   7.079  0.50 28.91           O  
Unresolved disorder model. using A
ATOM    439  CB AVAL    57      34.074  -7.497   3.880  0.50 27.07           C  
Unresolved disorder model. using A
ATOM    440  CB BVAL    57      34.084  -7.462   4.099  0.50 26.89           C  
Unresolved disorder model. using A
ATOM    441  CG1AVAL    57      34.225  -8.268   2.608  0.50 26.30           C  
Unresolved disorder model. using A
ATOM    442  CG1BVAL    57      34.250  -7.971   2.690  0.50 25.87           C  
Unresolved disorder model. using A
ATOM    443  CG2AVAL    57      33.782  -6.051   3.591  0.50 27.35           C  
Unresolved disorder model. using A
ATOM    444  CG2BVAL    57      33.810  -5.995   4.092  0.50 27.07           C  
Unresolved disorder model. using A
ATOM    850  N  AGLU   108      22.924 -39.763 -14.832  0.50 22.69           N  
Unresolved disorder model. using A
ATOM    851  N  BGLU   108      22.897 -39.774 -14.859  0.50 22.73           N  
Unresolved disorder model. using A
ATOM    852  CA AGLU   108      21.941 -40.430 -13.987  0.50 22.89           C  
Unresolved disorder model. using A
ATOM    853  CA BGLU   108      21.843 -40.351 -14.077  0.50 22.89           C  
Unresolved disorder model. using A
ATOM    854  C  AGLU   108      21.522 -39.504 -12.834  0.50 22.76           C  
Unresolved disorder model. using A
ATOM    855  C  BGLU   108      21.502 -39.422 -12.925  0.50 22.78           C  
Unresolved disorder model. using A
ATOM    856  O  AGLU   108      22.379 -38.947 -12.146  0.50 23.06           O  
Unresolved disorder model. using A
ATOM    857  O  BGLU   108      22.376 -38.794 -12.329  0.50 23.08           O  
Unresolved disorder model. using A
ATOM    858  CB AGLU   108      22.490 -41.771 -13.450  0.50 23.50           C  
Unresolved disorder model. using A
ATOM    859  CB BGLU   108      22.190 -41.724 -13.544  0.50 23.59           C  
Unresolved disorder model. using A
ATOM    860  CG AGLU   108      23.663 -41.643 -12.468  0.50 25.30           C  
Unresolved disorder model. using A
ATOM    861  CG BGLU   108      21.211 -42.099 -12.454  0.50 25.04           C  
Unresolved disorder model. using A
ATOM    862  CD AGLU   108      23.775 -42.801 -11.477  0.50 28.58           C  
Unresolved disorder model. using A
ATOM    863  CD BGLU   108      20.879 -43.542 -12.465  0.50 29.13           C  
Unresolved disorder model. using A
ATOM    864  OE1AGLU   108      23.482 -43.951 -11.888  0.50 30.56           O  
Unresolved disorder model. using A
ATOM    865  OE1BGLU   108      21.735 -44.308 -12.966  0.50 30.81           O  
Unresolved disorder model. using A
ATOM    866  OE2AGLU   108      24.149 -42.559 -10.296  0.50 27.68           O  
Unresolved disorder model. using A
ATOM    867  OE2BGLU   108      19.780 -43.904 -11.970  0.50 31.30           O  

1